Danone expands recall of infant formula batches in Europe

Weather - Sydney 9°C

Danone expands recall of infant formula batches in Europe

ECONOMY 06.02.2026

Danone expands recall of infant formula batches in Europe / Photo: © AFP

French food giant Danone recalled batches of infant formula in Britain, Spain, Croatia and Slovenia over the possible presence of a toxin, food safety authorities said on Friday, expanding the measure across Europe.

Change text size:

Several manufacturers have issued recalls in more than 60 countries since December of infant formula that could be contaminated by the cereulide toxin which can cause nausea, vomiting and diarrhoea.

Danone had already issued recalls of its infant formula to Austria, France, Germany, Hungary, Poland, Romania and Switzerland on Thursday, the company and national health authorities confirmed.

On Friday, the UK Food Standards Agency (FSA) said "Danone is recalling several Aptamil and Cow & Gate First Infant Milk and Follow on Milk formula products because cereulide toxin may be present in some batches of the products."

It previously recalled one batch of its Aptamil First infant formula in the UK because "cereulide toxin has been found in the product," the FSA said in January.

Swiss food giant Nestle also undertook a recall of several batches of infant formula in the UK at the start of January as a precaution.

Spain's food safety agency AESAN said on Friday that "further products and batches" from Danone's Almiron and Bledina brands "are being withdrawn from marketing channels", after a first cereulide alert in January.

Recalls dated to Friday also affected Croatia and Slovenia, according to an official EU portal listing the countries served by a Danone factory in Germany that used a contaminated ingredient.

Danone had not provided a complete list of the countries affected, nor the number of batches or packages.

The recalls are however larger in terms of batches than previous recalls announced by other companies since mid-January, according to data compiled by AFP.

Danone said on Thursday: "We want to reassure all parents: our infant formulas are safe. All of our baby formulas are produced in accordance with strict food safety norms and undergo rigorous controls before leaving our factories."

- Health risk fears -

The UK Health Security Agency (UKHSA) on Thursday said it was investigating 36 cases where children developed "symptoms consistent with cereulide toxin poisoning across the UK, after consuming implicated batches".

But no cases of severe illness have been confirmed as linked to the outbreak so far in the UK.

The recall of potentially contaminated infant formula has heaped scrutiny on Chinese firm Cabio Biotech, the supplier of an ingredient used in infant formula which is suspected of being tainted.

Headquartered in the central Chinese city of Wuhan, Cabio Biotech is one of the world's largest producers of ARA, a fatty acid used primarily in baby formula and food products.

Cereulide was discovered in ARA manufactured by Cabio Biotech.

S.Collins--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size:

The National Times - Danone expands recall of infant formula batches in Europe